On July 8, 2025, Rein Therapeutics, Inc. announced that their clinical trial for LTI-03 was put on hold by the FDA due to safety concerns identified in a rat study. The company plans to work with the FDA to resolve this issue as quickly as possible.
AI Assistant
REIN THERAPEUTICS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.